Characterisation and localisation of the endocannabinoid system components in the adult human testis by Nielsen, John E. et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Characterisation and localisation of the endocannabinoid system components in the
adult human testis
Nielsen, John E.; Rolland, Antoine D.; Rajpert-De Meyts, Ewa; Janfelt, Christian; Jørgensen,
Anne; Winge, Sofia B.; Kristensen, David M.; Juul, Anders; Chalmel, Frédéric; Jégou,
Bernard; Skakkebæk, Niels E.
Published in:
Scientific Reports
DOI:
10.1038/s41598-019-49177-y
Publication date:
2019
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Nielsen, J. E., Rolland, A. D., Rajpert-De Meyts, E., Janfelt, C., Jørgensen, A., Winge, S. B., ... Skakkebæk, N.
E. (2019). Characterisation and localisation of the endocannabinoid system components in the adult human
testis. Scientific Reports, 9(1), [12866]. https://doi.org/10.1038/s41598-019-49177-y
Download date: 03. Feb. 2020
1Scientific RepoRtS |         (2019) 9:12866  | https://doi.org/10.1038/s41598-019-49177-y
www.nature.com/scientificreports
characterisation and localisation 
of the endocannabinoid system 
components in the adult human 
testis
John e. nielsen1, Antoine D. Rolland2, ewa Rajpert-De Meyts  1, christian Janfelt3, 
Anne Jørgensen  1, Sofia B. Winge1, David M. Kristensen2,4, Anders Juul1, frédéric chalmel2, 
Bernard Jégou2 & niels e. Skakkebaek1
Heavy use of cannabis (marijuana) has been associated with decreased semen quality, which may 
reflect disruption of the endocannabinoid system (ECS) in the male reproductive tract by exogenous 
cannabinoids. components of ecS have been previously described in human spermatozoa and in the 
rodent testis but there is little information on the ECS expression within the human testis. In this 
study we characterised the main components of the ecS by immunohistochemistry (iHc) on archived 
testis tissue samples from 15 patients, and by in silico analysis of existing transcriptome datasets 
from testicular cell populations. The presence of 2-arachidonoylglycerol (2-AG) in the human testis 
was confirmed by matrix-assisted laser desorption ionization imaging analysis. Endocannabinoid-
synthesising enzymes; diacylglycerol lipase (DAGL) and N-acyl-phosphatidylethanolamine-specific 
phospholipase D (NAPE-PLD), were detected in germ cells and somatic cells, respectively. The 
cannabinoid receptors, CNR1 and CNR2 were detected at a low level in post-meiotic germ cells and 
Leydig- and peritubular cells. Different transcripts encoding distinct receptor isoforms (CB1, CB1A, 
CB1B and CB2A) were also differentially distributed, mainly in germ cells. The cannabinoid-metabolising 
enzymes were abundantly present; the α/β-hydrolase domain-containing protein 2 (ABHD2) in all germ 
cell types, except early spermatocytes, the monoacylglycerol lipase (MGLL) in Sertoli cells, and the 
fatty acid amide hydrolase (FAAH) in late spermatocytes and post-meiotic germ cells. Our findings are 
consistent with a direct involvement of the ecS in regulation of human testicular physiology, including 
spermatogenesis and Leydig cell function. The study provides new evidence supporting observations 
that recreational cannabis can have possible deleterious effects on human testicular function.
Possible adverse effects of cannabis (marijuana), a commonly used recreational drug, on male reproductive func-
tion, are a matter of concern. Frequent cannabis smoking has been repeatedly associated with decreased semen 
quality1–4 and increased risk of testicular germ cell cancer5,6. However, the mechanisms have not yet been elu-
cidated. It is not known whether cannabis acts directly on the human testis or indirectly through disruption 
of the regulation of the gonadal function by the central nervous system (CNS). The main psychoactive com-
ponent of cannabis, Δ9-tetrahydrocannabinol (THC), is an agonist of the endocannabinoid system (ECS), a 
well-conserved and ubiquitous signalling system, with multiple physiological roles. Among the natural agonists, 
anandamide (AEA) and 2-arachidonoylglycerol (2-AG) have been best characterised, particularly in CNS7,8. 
AEA is synthesised from phospholipid precursors by N-acyl-phosphatidylethanolamine-specific phospholipase 
D (NAPE-PLD) and 2-AG is synthesised from diacylglycerol (DAG) by a DAG-lipase (DAGL). The signalling 
of cannabinoids is mediated by several receptors, in particular two canonical receptors CNR1 and CNR2 (also 
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known as CB1 and CB2, respectively), both structurally defined as G-protein-coupled receptors7–9. Possible 
alternative receptors have also been identified10. The ECS signalling is further regulated by a complex system of 
degrading enzymes; AEA is metabolised by the fatty acid amide hydrolase (FAAH) and 2-AG predominantly by 
the monoacylglycerol lipase (MGLL, also known as MAGL), but alternative metabolising pathways e.g. by oxida-
tion have been described7,8.
The ECS has been best described in the CNS and in the immune system, but ECS is also involved in bone 
metabolism and reproductive functions4,8,11. Studies in rodents demonstrated the presence of CNR1 protein in 
germ cells, Leydig cells and possibly also Sertoli cells11–15. Other ECS components were identified in rodent testes 
mainly at the transcriptional level, including CNR2 and FAAH in Sertoli cells, and FAAH, NAPE-PLD, MGLL 
and DAGL in germ cells (reviewed in 11). Ablation of Cnr1 in mice had systemic and local effects on reproductive 
function; including decreased serum LH and testosterone levels16, but also disturbance of chromatin remodelling 
in spermatids13,14.
Previous human investigations have focused on identification of ECS components in spermatozoa and asso-
ciation of their presence with selected parameters of sperm quality and function1,2,17–22. The ECS receptors were 
found in human spermatozoa, however with some discrepancies; while most studies demonstrated the presence 
of CNR1 alone17,18, some studies detected also in sperm the other canonical receptor, CNR2, albeit at a much 
lower expression level18,19. More recently, a distinct role of the ECS in sperm activation was documented by data 
showing that progesterone-induced degradation of 2-AG in the sperm plasma membrane by ABHD2 is necessary 
to activate CatSper channel21. It was also experimentally demonstrated that excess of 2-AG indeed impaired func-
tion of human spermatozoa in vitro, causing premature acrosome reaction and loss of sperm motility22.
In contrast to the numerous studies on human spermatozoa, very few studies of ECS have been carried out in 
human testis tissue. The existing data concern mainly the expression of transcripts of the ECS receptors and their 
variants, following the initial discovery of the cannabinoid receptor mRNA in the testis at the time of the human 
receptor’s cloning23. Alternative splice variants of CNR1, encoding non-canonical CB1A and CB1B protein iso-
forms were detected at a low expression levels in human testis tissue24. An additional transcript isoform of CNR2 
(designed as CB2A, which encodes the same protein as the initially-characterized CB2B isoform), was also found 
to be expressed at a much higher level in human testis than in any other tissue, but this finding differed from the 
variant distribution in rodents25. Cellular localisation of these transcripts was not reported.
The aim of this study was to close some of the above-mentioned gaps of knowledge, and to investigate the 
expression and cellular localisation of the main ECS components, including the canonical receptors, their var-
iants, and metabolic enzymes in adult human testes at the protein and transcriptional level. We were curious 
whether the ECS system found in spermatozoa is also present in earlier stages of spermatogenesis and whether 
human somatic cells contain some elements of the ECS. In this reference-providing study, we used immunohis-
tochemistry (IHC) on human testis samples from tissue archives, and in silico analysis of the ECS transcripts and 
IHC data in existing datasets. For validation of the antibodies, we examined samples of human extra-testicular 
tissues, including epididymis. We also performed quantitative RT-PCR (qPCR) validation of the expression of 
ECS-receptors and their non-canonical isoforms. In addition, we investigated the presence of endocannabinoids 
AEA and 2-AG in testis tissue by matrix assisted laser desorption ionization (MALDI) imaging analysis. Taken 
together the data indicate that the ECS is present in the human testis and is likely to be directly involved in testic-
ular function, particularly in regulation of spermatogenesis.
Results
Localisation of the ECS components in the adult testis at the protein level. We investigated by 
IHC the spatial organisation of the ECS components necessary for the ECS machinery to function. The IHC 
results in the testis are summarised in Table 1, separately for each cell type, and representative images are shown 
in Figs 1–3.
The antibodies, listed in Table 2, were selected and validated as described in Materials & Methods and in 
Supplementary Information. Additional validation of all antibodies included testing in other tissues, including 
epididymis and efferent ducts (the tissues of importance for testis function) and several other tissue types, with 
known expression levels of ECS. These data are summarised in Supplementary Table S1, with representative 
examples shown in Supplementary Fig. S1.
Below, we briefly describe the protein expression pattern of the endocannabinoid-synthesising enzymes, the 
receptors and the endocannabinoid-metabolising enzymes. Because animal studies stipulated the involvement 
of ECS in distinct testicular functions, such as steroidogenesis, meiosis and spermiogenesis, we summarised 
the localisation of the ECS components in different compartments separately. The patterns of staining are first 
described in the seminiferous epithelium, with focus on different stages of germ cell maturation and in Sertoli 
cells, followed by the localisation of the ECS components in the interstitial compartment.
The seminiferous epithelium and maturation stages of germ cells. In germ cells, the localisation of several ECS 
components, was distinct in different maturation stages. The strongest expression was observed in post-meiotic 
germ cells. In spermatogonia a low-level cytoplasmic reaction of CNR2 was observed, and no CNR1 was detected 
(Fig. 2). CNR2 was more clearly expressed in the cytoplasm of late spermatocytes and round spermatids. CNR1 
was also detected in germ cells, but in an unusual nuclear localisation. The strongest CNR1 expression was 
observed in pachytene spermatocytes (Fig. 2). An unusual nuclear reaction in germ cells (except early sper-
matocytes) was also noted in a subset of samples for DAGLA, a 2-AG-synthesizing enzyme, while no convinc-
ing staining for AEA synthesizing enzyme NAPE-PLD was detected in germ cells. The metabolising enzyme 
FAAH (2-AG-degrading) was abundantly expressed in the cytoplasm of late spermatocytes, round spermatids 
and late spermatids (Fig. 3). Another 2-AG-degrading enzyme, MGLL, was detected in nuclei of spermatids in 
a subset of samples, while in other samples the reaction was predominantly observed in Sertoli cells. ABHD2 
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(AEA-degrading) enzyme was expressed at a moderate level in spermatogonia, and more abundantly in late sper-
matocytes and spermatids (Fig. 3).
Sertoli cells, the somatic cells of the seminiferous epithelium, did not show convincing staining for the two 
canonical ECS receptors, and in general did not demonstrate a strong presence of the ECS components, except 
for NAPE-PLD and MGLL in a subset of samples. The AEA synthesizing enzyme, NAPE-PLD, showed a weak 
reaction in Sertoli cells (Fig. 1). The 2-AG-degrading MGLL displayed a heterogeneous reaction, with a strong 
staining in some samples, but rather weak in others, without any association with clinical diagnosis or quality 
of spermatogenesis. The MGLL reaction in Sertoli cells seemed to be weakest around spermatogonia. No other 
degrading enzymes, ABHD2 or FAAH, were detected in Sertoli cells.
Leydig cells and the interstitial compartment. The AEA-synthesising enzyme NAPE-PLD was strongly expressed 
in the cytoplasm of a subset of Leydig cells, while the 2AG-syntesizing DAGLA was not convincingly present, 
except a weak reaction in some cells (Fig. 1). The canonical ECS receptor, CNR1, showed a weak reaction, while 
CNR2 staining was detected quite clearly in peritubular cells and in a subset of Leydig cells. The peritubular cell 
reaction was though weaker than in epithelial and myoid cells of blood vessels, which are known to express CNR1 
(Fig. 2). Virtually no expression of endocannabinoid degrading enzymes, ABHD2 and FAAH, was observed in 
the interstitial compartment, except some weak trace reaction in the cytoplasm of Leydig cells. MAGL/MGLL 
staining was weakly positive in Leydig cells and strongly positive in blood vessel walls (Fig. 3).
Transcriptional profile of the ECS in isolated human testicular cell populations. To investigate 
the expression of the ECS components at the transcript level we first used existing RNA-sequencing (RNA-seq) 
data from human testicular cells26; (Supplementary Table S3). We found a consistent mRNA expression for both 
synthesising and degrading enzymes in distinct cell types, correlating to some extent with the protein data. 
2-AG-synthesising DAGLA was detected at a lower level, in all cell types except spermatids, while DAGLB was 
highly expressed in Sertoli cells and peritubular cells. NAPEPLD, on the other hand, was mainly detected in sper-
matids. The expression of FAAH was strong and specific to spermatocytes and spermatids, supporting well the 
IHC data, while the expression of MGLL was very low in germ cells but clearly detectable in Sertoli- and Leydig 
ECS Component N
Germ cells Somatic cells
BVSpg
early-
Spc P-Spc late-Spc round-Spt elongated-Spt Sertoli Peritub. Leydig
• Synthesising enzymes
NAPE-PLD protein 14 − − − − − − C+ or +/− C+/− C+/++/− C+
NAPEPLD transcripts n.a. + ++ n.a. + + + n.a.
DAGLA protein 11 N+/++/− − N+ (5/11) N+ (5/11) N+/++ (5/11) − N+ or +/− − N+/− N +/−
DAGLA transcripts n.a. + − n.a. + + + n.a.
DAGLB transcript n.a. + + n.a. +++ ++ + n.a.
• Receptors (canonical and isoforms)
CNR1 protein 10 − − N++/+* N++/+ N++/− − − − C+/− −
CB1 RNA isoform n.a. n.a. + + n.a. − − + n.a.
CB1A RNA isoform n.a. n.a. + + n.a. − − + n.a.
CB1B RNA isoform n.a. n.a. + + n.a. − − − n.a.
CNR2 protein 11 C+/− − C++ C++ C++ C++ − C++ − C+++
CB2B RNA isoform n.a. n.a. − − n.a. − − − n.a.
CB2A RNA isoform n.a. n.a. + + n.a. − − − n.a.
• Catabolic/degrading enzymes
ABHD2 protein 13 C+/++/− C+/− C++ C++ C++ C++/+ − − C−/+ −
ABHD2 transcripts n.a. +++ ++++ n.a. ++ ++ +++ n.a.
FAAH protein 13 − − C++ C++ C++ C++ − − C−/+ −
FAAH transcripts n.a. ++++ +++ n.a. − − + n.a.
MGLL protein 15 − − − − C/N−/+ (9/15) C/N−/+ (9/15) C+++6/+ (9/15) − C+/− C++/−
MGLL transcripts n.a. + + n.a. +++ ++ ++ n.a.
Table 1. Summary of the results showing predominant expression pattern of the ECS components in specific 
testicular cell types, grouped into germ cells and somatic cells. Immunohistochemical (IHC) data are shown in 
upper lines, with the subcellular protein localisation distinguished as nuclear (N) or cellular (C). Transcriptome 
data from RNA-sequencing (RNA-seq) for available cell types are listed underneath in italics. Note that the 
RNA-seq data for spermatocytes did not distinguish any specific stages, and that the expression of the receptor 
RNA isoforms was studied by qPCR. Abbreviations: Spg: spermatogonia, Spc: spermatocytes, P-Spc: pachytene 
spermatocytes, Spt: spermatids, Peritub: peritubular cells, BV: blood vessels. N: nuclear staining, C: Cytoplasmic 
staining, *localised intra-nuclear reaction. The IHC scoring is explained in the Methods section, ‘−‘ denotes 
no staining, ‘n.a.’ – cell type not available for transcriptional analysis. RNA-seq data are classified as strongly/
moderately expressed (++++/+++/++), detectable (+) or undetectable (−).
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cells. Additionally, ABHD2 transcripts were readily detected in all cell types, with highest expression level in 
round spermatids.
The expression levels of CNR1 and CNR2, however, were below detection threshold in all cell types (maxi-
mum expression of 0.57 and 0.17 FPKM, respectively). We therefore undertook qPCR experiments (Fig. 4), for 
which we ensured to design primers specific for canonical isoforms as well as for non-canonical isoforms of both 
CNR124,25 and CNR225. A relatively low but consistent expression signal was found for both the canonical CB1 
isoform and the non-canonical CB1A isoform in Leydig cells, spermatocytes and spermatids. The non-canonical 
CB1B isoform was also detected, at very low levels in spermatocytes and spermatids, and at a slightly higher level 
in total testis samples, suggestive of a stronger expression in at least one additional testicular cell type. Regarding 
CNR2, the canonical CB2B isoform could not be detected at all. However, the non-canonical CB2A isoform was 
detected at low but consistent levels in spermatocytes, and to a lower extent in spermatids. Importantly, the puri-
fication and sequencing of PCR fragments confirmed the specificity of the expression signals for all four receptor 
isoforms. A summary of the data extracted from the RNA-seq human dataset is shown for each available cell type 
in Table 1, together with the protein data.
Qualitative detection of endocannabinoid 2-AG in human testis tissue. After detecting the pres-
ence of EC-synthesising enzymes, we then investigated whether the most common endocannabinoids, AEA and 
2-AG are produced within the testis. By MALDI imaging methodology, we first analysed differentially distributed 
lipids in main testicular compartments. The PC (36:2) lipid (PC = phosphatidylcholine) detected as the sodium 
adduct at m/z 824.5566 was found to be associated with interstitial cells, while the PC (38:5) lipid detected as the 
sodium adduct at m/z 846.5409 was found within the intra-tubular compartment (Fig. 5). Using this basic sep-
aration of the two main compartments in the testis, we next made an examination for AEA and 2-AG. We were 
not able to find any detectable levels of AEA, likely due to the amount below the detection threshold. In contrast, 
we found 2-AG detectable as its potassium adduct at m/z 417.2402 – although at a very low signal intensity, with 
a localisation dispersed between the interstitial and tubular cells, as shown in Fig. 5. The extreme selectivity pro-
vided by the Orbitrap spectrometer could be observed by changing the imaged mass window to m/z 417.2422 
(corresponding to an increase of the mass window by 0.002 Th), which made the distribution of 2-AG completely 
disappear. The signal was present in a very small mass window and disappeared upon such a small mass change, 
hence the signal was with very high probability due to 2-AG (or an isomer) and not an arbitrary background 
Figure 1. Immunohistochemical expression of the endocannabinoid-synthesising enzymes, NAPE-PLD and 
DAGLA, in the adult human testis. The images on the left show a general expression pattern, and a higher 
magnification of an area within a stippled line is shown on the right. All pictures show a low magnification 
image of negative controls in the right upper corner. NAPE-PLD was present in Leydig and Sertoli cells. 
DAGLA was present predominantly in the nuclei of germ cells, with only weak reaction detected in Sertoli and 
Leydig cells. L (leptotene) and P (pachytene)  indicate early and late spermatocytes, respectively.
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interference. The compound was also detected in adjacent tissue slices using the related desorption electrospray 
ionization mass spectrometric imaging (DESI-MSI) technique on a similar Orbitrap mass spectrometer with 
much better signal intensities, but at a resolution too low to spatially assign the origin of the signal.
Discussion
Although several of the ECS components have been detected previously in human ejaculated spermatozoa2,3,17–22, 
our study is the first to demonstrate the presence of a specific pattern of this signalling pathway in various human 
testicular cell types, including germ cells at different stages of spermatogenesis, and in the somatic cells. We 
clearly demonstrated that the human testis has a machinery to synthesise and metabolise endocannabinoids, 
which are recognised by different testicular cell types (i.e. their receptors) within the seminiferous epithelium 
and the interstitial tissue. Interestingly, we detected a germ cell maturation stage–specific pattern of the ECS 
expression, with apparent paucity of most of the ECS components in early spermatocytes, distinct expression in 
pachytene spermatocytes, and the strongest expression in the post-meiotic spermatids.
The discovery of a CatSper channel activation in sperm by progesterone-dependent ABHD2 which removes 
2-AG inhibiting this channel21, prompted us to investigate at which stage of germ cell maturation this enzyme and 
other elements of ECS appear, and whether 2-AG is produced in the testis tissue outside of sperm membranes. 
Surprisingly, we detected the presence of ABHD2 already in spermatogonia, but not in early spermatocytes, 
and this novel finding suggests an ECS function already in pre-meiotic germ cells, perhaps linked to commit-
ment into meiosis, as suggested in rodent studies27,28. As expected, we found abundant ABHD2 protein and 
transcripts in spermatocytes and spermatids, and this is consistent with the subsequent function of this enzyme 
in transcriptionally inactive spermatozoa. We also found in germ cells an AEA-degrading enzyme, FAAH, with 
a robust expression at the transcriptional and protein level in late spermatocytes and spermatids, which supports 
previously reported findings of FAAH in ejaculated spermatozoa2,18. MGLL, which also metabolises 2-AG, was 
expressed in spermatids at much lower level, but was surprisingly abundant in Sertoli cells, however, with marked 
heterogeneity of expression between studied samples. We did not observe any association between MGLL expres-
sion level and the different stages of spermatogenesis, especially the presence of post-meiotic cells. We noticed 
though that the intensity of the MGLL staining was somewhat polarised, weakest near spermatogonia, suggesting 
Figure 2. Immunohistochemical expression in human testis tissue of the two canonical EC receptors; CNR1 
and CNR2. The images on the left show a general expression pattern, and a higher magnification of an area 
within a stippled line is shown on the right. All pictures show a low magnification image of negative controls 
in the right upper corner. CNR1 staining (upper images) is visible within nuclei of primary spermatocytes and 
in the cytoplasm of Leydig cells. CNR2 (bottom images) is localised in the cytoplasm of all types of germ cells, 
except early spermatocytes, and in somatic cells, especially in Leydig cells and peritubular cells. L (leptotene) 
and P (pachytene) indicate early and late spermatocytes, respectively.
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that that pre-meiotic germ cells may need higher levels of 2-AG, as recently proposed in an elegant study of ECS 
components in rat testis28. Hence, we hypothesise that MGLL in Sertoli cells may be needed to metabolise 2-AG 
produced in post-meiotic germ cells and shed within residual bodies.
The proposed constant synthesis of 2-AG within sperm cell membranes to protect from premature sperm 
capacitation21 would also require presence of a diacylglycerol lipase, and its transcription during earlier stages of 
spermatogenesis. Indeed, the analysis of our RNA dataset revealed the presence DAGLA and DAGLB transcripts 
in both germ cells and somatic cells. The protein data, however, indicated the presence of DAGLA protein mainly 
in cell nuclei, and no suitable antibody was available for DAGLB. The public database, Human Protein Atlas29 
reported the presence of DAGLA protein mainly in Leydig cells, hence more work is needed to firmly establish 
the cell type producing 2-AG within the testis.
In support of the presence of synthesizing enzymes in the testis, we detected their product, 2-AG in frozen 
testis tissue by MALDI-MS imaging. The low signal intensity in these experiments did not allow a firm conclu-
sion concerning the cellular localisation. While such low intensities in other low-resolution mass spectrometry 
systems (e.g. ion traps and MALDI-TOF systems) might be dismissed as interferences with other background 
compounds, the risk of such interferences was greatly reduced by the use of a high-resolution Orbitrap mass 
spectrometer. With the same method we did not detect the other best-known endocannabinoid, AEA, reported 
by others to be present together with 2-AG in human seminal fluid30–32. We found though some supporting evi-
dence for the synthesis of AEA in testicular tissue, as the required enzyme NAPE-PLD was detected in Leydig 
cells and in Sertoli cells. NAPEPLD transcripts were present in these somatic cell types but were also detected in 
round spermatids. One of the antibodies screened in the preliminary phase of the study detected also NAPE-PLD 
in round spermatids, but only in the nuclei. This enzyme was not studied previously in the human testis tis-
sue, only in ejaculated spermatozoa, where NAPE-PLD protein was described in the post-acrosomal region and 
mid-piece2,18. Data available in public databases are also somewhat contradictory concerning this enzyme, so fur-
ther studies concerning AEA synthesis in the testis are needed. By contrast, the existing data agree on the robust 
expression of the AEA-metabolising enzyme, FAAH, in late spermatocytes and in spermatids. This is consistent 
with a hypothesis that the level of AEA or another natural FAAH substrate must be kept very low during meiosis 
and post-meiotic maturation of germ cells.
It is possible that endocannabinoids, especially 2-AG, might act in transcriptionally inert spermatozoa in a 
non-genomic manner. In transcriptionally active cell types in the testis, the presence of several components of the 
ECS system suggests a genomic function, which is mediated by specific receptors. The existing information on the 
ECS receptors and their variants in the testis is fragmentary and sometimes contradictory, with apparent species 
differences25. CNR1 and CNR2, or CNR1 alone were described in murine Leydig cells and murine and frog germ 
cells, leading to a proposal that activation of CNR1 in Leydig cells is likely involved in steroidogenesis, while 
CNR2 in spermatogonia B might promote meiotic entry in mice15,33,34. In humans the data are scarce, and largely 
limited to expression at the RNA level in whole testis tissue extracts, including the testis-dominant expression of 
CB2A variant24,25. At the protein level previous human studies only investigated ejaculated spermatozoa; CNR1 
alone was detected in one study17, while both CNR1 and CNR2 were found by other groups19,20,34.
We attempted to localise the EC receptors by IHC, but few antibodies are available, and none can distinguish 
the isoforms. We tested different antibodies (Supplementary Information), and three of the four CNR1 antibodies 
showed an unexpected localisation in germ cells within the nuclei. The most robust antibody showed an espe-
cially strong signal in dense structures in pachytene spermatocytes. Validation of the CNR1 antibody by Western 
blotting and by pre-absorption with corresponding blocking peptides confirmed its specificity (Supplementary 
Information). We were though unable to obtain enough isolated spermatocytes from patients to corroborate this 
finding in subcellular fractions, thus, we cannot completely exclude cross-reactivity.
While the presence of CNR1 in Leydig cells is consistent with previous studies in rodents, it is difficult to 
explain the presence of a G-protein coupled receptor (GPCR) within a cell nucleus, however there are some 
reports of GPCRs active in the nucleus35. Interestingly, an unexpected localisation of some translation initiation 
proteins but without actual translational activity, was detected in the XY body of murine spermatocytes36. The 
authors of that study proposed a “temporal poising” hypothesis that the XY body composed mainly of inert 
chromatin could be a storage place for factors needed to be active in round spermatids36. Such a way of a quick 
activation of the ECS during spermiogenesis is conceptually attractive but remains a hypothesis.
Antibody name and targeted protein Dilution
Pre-
treatment 
buffer Species Provider (Catalogue Nr.)
ABHD2: Monoacylglycerol lipase (α/β-hydrolase 
domain-containing protein 2) 1:100 Citrate Rabbit Sigma (HPA005999)
CNR1 (CB1-R): Cannabinoid-binding receptor-1 1:400 Citrate Rabbit Abcam (ab23703)
CNR2 (CB2-R): Cannabinoid-binding receptor-2 1:400 TEG Rabbit Santa Cruz Biotechnology (sc-25494)
DAGL(A): Diacyglycerol lipase A 1:50 Citrate Rabbit Sigma (HPA062497)
FAAH: Fatty acid amide hydrolase 1:400 Citrate Rabbit Sigma (HPA007425)
MAGL (MGLL): Monoacylglycerol lipase 1:300 Citrate Goat Abcam (ab77398)
NAPE-PLD: N -acyl-phosphatidyl-ethanolamine-
specific phospholipase D 1:100 TEG Rabbit Sigma (HPA024338)
Table 2. Antibodies used in the study, listed in alphabetical order.
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We can also speculate that CNR1 can have a discreet function within the cell nucleus of germ cells during 
transition from pre-meiotic spermatocytes to post-meiotic stages, including spermatids. Indeed, studies of cnr1 
knock-out mice evidenced problems with chromatin remodelling and histone displacement in spermatids, likely 
resulting from disturbed steroid hormone levels13,14. Interestingly, these mice also displayed premature motility 
of sperm in caput epididymis37, and a 2-AG gradient was noted along epididymis38. Studying ECS in sperm and 
epididymis was not the principal aim of our study. However, while testing the CNR1 antibody in other tissues we 
also found an interesting pattern in the epididymis and efferent ductules. A remarkably strong CNR1 reaction 
was observed in cell membranes of epithelium of the efferent ductules, while in epididymis groups of epithelial 
cells resembling clear cells were strongly and specifically stained, both in the cell membranes and the nuclei (see 
Supplementary Table S1 and Fig. S1). These distinct subcellular localisations of CNR1 in a subset of cells in testis, 
efferent ductules and epididymis need to be independently confirmed and the biological implications further 
investigated.
Figure 3. Immunohistochemical staining for the EC-degrading enzymes ABHD2, FAAH and MGLL in the 
human testis. The images on the left show a general expression pattern and the images on the right show a 
higher magnification of an area within a stippled line. All pictures show a low magnification image of negative 
controls in the right upper corner. Note that the ABHD2 (top images) is expressed in the cytoplasm of all stages 
of germ cell maturation, except early spermatocytes. FAAH reaction (middle row) is strongest in post-meiotic 
germ cells, including late spermatocytes and spermatids. MGLL protein (bottom images) is abundant in Sertoli 
cells. L (leptotene) and P (pachytene) indicate early and late spermatocytes, respectively.
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As far as the CNR2 is concerned, we found the protein moderately present in a subset of spermatogonia, but 
not in primary spermatocytes, and then re-appearing in post-meiotic germ cells. This is the first report of the 
presence of CNR2 receptor in human spermatogonia, and the pattern observed in our study is consistent with 
previous studies in mice, which demonstrated the involvement of the ECS in the mitosis-meiosis switch15,34. 
CNR2 was also present in the interstitial compartment, particularly in peritubular cells where the ECS signalling 
likely has another function.
A somehow contradictory result from our study is that protein data were not always supported by RNA data, 
including the virtual absence of gene expression for both CNR1 and CNR2 as evidenced by RNA-seq. We hypoth-
esised that perhaps a low expression of poorly characterised truncated receptor isoforms could be an explanation 
of the observed atypical cellular localization of staining and the paucity of the canonical receptor transcripts. 
Indeed, we found by qPCR a low expression level of all three CNR1 transcript isoforms (CB1, CB1A and CB1B) 
and of one CNR2 transcript isoform (CB2A) in distinct testicular cells, mainly in spermatocytes and round sper-
matids, but had no data available for spermatogonia. Hence, we believe that a differential expression of the CNR1 
variant truncated isoforms in human spermatocytes could be an explanation of the unusual localisation patterns. 
We could not confirm that on the protein level, because of lack of isoform-specific antibodies. Further studies at 
the level of receptivity of the ECS are therefore needed to clarify the respective role of each receptor isoform in 
the human adult testis.
In summary, we have characterised the localisation of main components of the ECS in the human testis and 
the emerging picture is illustrated schematically in Fig. 6. Within the seminiferous epithelium a balance between 
Figure 4. Expression profiles of transcript isoforms coding for CB1, CB1A, CB1B and CB2A. Quantitative 
PCR (qPCR) experiments were performed on cDNA from isolated human Leydig cells (n = 4; LC), peritubular 
cells (n = 2; PC), Sertoli cells (n = 2; SC), pachytene spermatocytes (n = 4; SPC), round spermatids (n = 4; 
SPT) and total testis tissue (n = 4; TT). Histograms represent mean expression (relative to RPLP0) ± SEM. 
Following evaluation of normality (Shapiro–Wilk test and D’Agostino’s K-squared test) and of homogeneity of 
variances (Brown-Forsythe test), global analysis of variances was achieved with One-way ANOVA (CB1 and 
CB1A) or with Kruskal–Wallis one-way analysis of variance (CB1B and CB2A). Pairwise comparisons were also 
performed using unpaired Student’s t-test (CB1 and CB1A) or with Mann–Whitney U test (CB1B and CB2A). 
One, two or three stars denote statistical significance with p < 0.05, p < 0,01 or p < 0.005, respectively. p-values 
close to significance are also indicated.
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the synthesis and degradation of endocannabinoids is likely to be involved in the regulation of spermatogenesis. 
We noted that the transition from spermatogonia to early primary spermatocytes (i.e. from mitosis to meio-
sis) was associated with a relative silencing of the ECS receptors and metabolising enzymes. The opposite was 
observed in post-meiotic germ cells, with high expression levels of the ECS catabolising enzymes, likely needed 
to maintain a high turnover of endocannabinoids during spermiogenesis or provide their supply for use in sper-
matozoa outside the testis. The receptor signalling at these stages requires further investigations, but it never-
theless appears that CNR1 or its isoforms may be enriched in spermatocytes for an immediate action in specific 
functions related to chromatin changes during meiosis and spermiogenesis. Sertoli cells displayed lower levels of 
the ECS components, with absence of the receptors, perhaps related to the low proliferation of Sertoli cells in the 
adult testis. Peritubular cells also contain ECS, and express one of the canonical receptors, CNR2. The Leydig cells 
are characterised by a strong expression of the AEA-synthesising enzyme NAPE-PLD and the presence of both 
receptors, CNR1 and CNR2, in combination with a relative paucity of the degrading enzymes, possibly reflecting 
the participation of AEA in steroidogenesis.
In conclusion, the specific and differential expression patterns suggest a direct involvement of the ECS in the 
physiology of the human testis. The findings are relevant in relation to studies showing associations between a use 
of marijuana and changes in semen quality and reproductive hormone levels in young men1–4,18–22 as well as with 
regard to plans of cannabis legalisation39. Clearly, more studies of the endocannabinoid function in the human 
reproductive organs are warranted to address more comprehensively the health impact of cannabis.
Materials and Methods
tissue samples. The testis tissue samples for the IHC analyses were excised from tumour-free periphery of 
orchiectomy specimens from 15 adult patients with testicular germ cell cancer. Only the specimens with tumours 
typical for young adults, i.e. derived from germ cell neoplasia in situ (GCNIS), either seminoma or nonseminoma, 
were included. None of the orchidectomy specimens contained sex-cord stromal cell tumours, e.g. Sertoli cell- 
or Leydig cell tumours. After pathologist’s evaluation, the remaining parts of the orchidectomy specimens were 
divided into small fragments (including tumour tissue, preserved testicular tissue, and epididymis), fixed over-
night in GR fixative (modified Stieve fixative) or buffered formalin, and subsequently embedded in paraffin. The 
samples of preserved testicular parenchyma were evaluated by experienced pathologists to determine whether 
preinvasive GCNIS or any microinvasive tumour were present and to characterise spermatogenesis within the 
samples. Care was taken to select for this study tissue fragments with complete spermatogenesis including a 
good number of late spermatids, and without any pathological changes. The presence of GCNIS of micro-inva-
sive tumour cells was excluded by IHC staining for specific markers40. Together with epididymis we also exam-
ined efferent ducts, which have not been previously reported in the literature with regard to the ECS expression. 
In addition, formalin-fixed and paraffin-embedded archival blocks of other human tissues from anonymous 
donors were included as controls. The following tissues with reported expression levels of ECS components were 
included: adrenals, skin, prostate and samples of placenta collected at term. For MALDI imaging analysis, frozen 
tissue samples were obtained from multi-organ donors.
ethical approval. A regional medical research ethics committee of the Capital Region of Copenhagen 
approved the use of human tissues stored in the biobank at Department of Growth and Reproduction for gene 
expression studies (permit number H-16019636). All patients have given informed consent for donating the 
residual tissues for research. The protocol for MALDI investigations was approved by the local ethics com-
mittees in Rennes and informed consent was obtained from all donors or their next of kin (CCPPRB Rennes; 
Figure 5. Detection of 2-AG in human testis. (A) MALDI imaging with blue colour showing a lipid associated 
with intra-tubular cells and green colour marking a lipid associated with interstitial cells, while red stain shows 
recognition of 2-AG dispersed among the tubules. (B) The frozen section after MALDI imaging showing the 
structure of the testis.
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authorization 05/39–566; Agence de la Biomédecine; authorization #PFS09-015). All laboratory procedures and 
data evaluations have been performed in accordance with the Helsinki II Declaration and strict confidentiality.
Antibodies. The primary antibodies used in this study, their sources and dilutions, and pre-treatment con-
ditions are shown in Table 2. The antibodies were selected based on the previous performance in IHC of other 
tissues reported in the literature. Most of the commercial antibodies underwent extensive validation of their 
specificity by the suppliers, including Western blotting, and in all Sigma antibodies also IHC testing in a range of 
tissues, available in the public database Human Protein Atlas (www.proteinatlas.org), which also reports the pres-
ence of transcripts29. Several different CNR1 antibodies were tested before selecting the most robust one (Abcam) 
for the final study (Supplementary Table S2). Three of the four tested CNR1 antibodies demonstrated unusual 
nuclear localisation of staining in the testis. The selected antibody was additionally validated by Western blotting 
with and without a blocking peptide, and pre-absorption step in the IHC protocol (Supplementary Figures S2 
and S3). We also did additional testing of the specificity of the antibodies by comparing staining patterns in testis 
tissue fixed in different fixatives, and in other human tissues known to have active ECS, including epididymis 
(Supplementary Table S1 and Fig. S1). Together with the epididymis we also examined efferent ductules, in which 
the ECS components have not been studied previously. The antibodies giving a staining pattern consistent with 
the localisation and role of the ECS components in these tissues were considered specific.
Western blotting. Protein was isolated from frozen testis tissue samples containing normal seminif-
erous tubules without presence of malignant germ cells. Protein concentration of samples was estimated 
with The Micro BCATM Protein Assay Kit (Thermo Scientific). Western blotting was performed as previously 
described41 with 10 µg protein loaded in each lane. For detection of chemiluminescence, SuperSignal West Femto 
Chemiluminescent Substrate was used according to manufacturer’s instructions (Fisher Scientific, Roskilde, 
Denmark). Primary antibodies against CNR1 (Abcam) and β-Actin (Santa Cruz, used as loading control) were 
diluted 1:200, while secondary antibodies were diluted 1:1000. Blocking with immunizing peptide, corresponding 
to C terminal amino acids 461–472 of CNR1, was conducted according to the manufacturer’s protocol (Abcam), 
with one adjustment: a 10-fold higher amount of blocking peptide to primary antibody was used (instead of 
2-fold). The experiment was conducted twice, and a representative example is shown in Supplementary Fig. S2.
Figure 6. Graphical summary of the findings of this study illustrating the general expression patterns 
(transcripts and protein combined) of the main components of the endocannabinoid system (ECS) in different 
cell types of the human adult testis. All germ cell types are depicted with blue nuclei, and the somatic cell types 
with orange nuclei. The ECS components are grouped into the synthesising enzymes (with the main products 
shown in parentheses), the receptors and the catabolic enzymes (main substrates in parentheses). Germ cell 
maturation stages are shown in the upper panel, and the somatic cells at the bottom of the graph. Uncertain 
expression patterns, with some discrepancy between the transcript and protein levels, are denoted by question 
marks. The asterisks refer to uncertain subcellular location of the protein (nuclear). The testicular cell types with 
the greatest activity of the ECS are shaded in pink: the post-meiotic germ cells (upper panel) and Leydig cells 
(bottom).
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immunohistochemistry. The IHC staining was conducted according to a standard indirect peroxidase 
method, as previously described, with some minor modifications42. In brief, tissue sections were subjected to 
heat-induced antigen retrieval in a pressure cooker (medical decloaking chamber, Biocare, Concord, CA, USA), 
either in 0.01 M citrate buffer (pH 7.4) or in TEG buffer (10 mM Tris, 1 mM EDTA, 0.05% Tween 20, pH 8.5) 
at 110 °C for 10–30 minutes. Endogenous peroxidase was blocked with 1% (v/v) H2O2 in methanol for 30 min. 
Unspecific staining was blocked using 0.5% skimmed milk in Tris-buffered saline (TBS) for 30 min. Sections 
were incubated overnight at 4 °C or room temperature with the primary antibodies diluted in TBS in a humid-
ified chamber and then incubated for 30 min with the species-appropriate ImmPRESS HRP (peroxidase) sec-
ondary antibody. Between all steps (except after the blockage of unspecific staining) the sections were washed in 
TBS. Visualization was performed using ImmPACT DAB peroxidase (HRP) substrate or acetyl carbazole (ACE) 
(Vector Laboratories). The sections were subsequently counterstained with Meyer’s haematoxylin, and mounted 
on glass slides.
IHC controls: For negative controls, serial sections were processed with the primary antibody replaced by 
the dilution buffer alone. Sections of other tissues known to express the studied protein were used as positive 
controls. The immunostaining of other (extra-testicular) human tissues was performed with a slightly different 
protocol as these tissues were formalin-fixed. Pressure cooking heating was reduced to 10 minutes and antibodies 
were applied overnight at room temperature. For the polyclonal CNR1 antibody with the unusual localisation 
pattern in the testis (Abcam, ab23703), the IHC staining was supplemented by a pre-absorption step with block-
ing peptide, used by the manufacturer for immunisation (Abcam ab50542). The antibody in 1:400 dilution was 
thoroughly mixed with a 10-fold excess of the CNR1 blocking peptide and then applied on tissue sections. The 
rest of the staining protocol was as described above. The IHC with the peptide competition was repeated in three 
independent experiments, and a representative example is shown in Supplementary Fig. S3.
IHC evaluation and scoring: Three investigators evaluated systematically all IHC slides. The sections were first 
examined manually on a Nikon Microphot-FXA microscope, then were scanned on a slide scanner, NanoZoomer 
2.0 HT (Hamamatsu Photonics, Herrsching am Ammersee, Germany) and analysed using the software NDPview 
version 1.2.36 (Hamamatsu Photonics). The observed IHC staining pattern and intensity was classified according 
to a pre-defined arbitrary scoring system: +++, strong staining in all cells of a given type in the sample; ++, 
staining in nearly all cells of a given type; ++/+, strong staining prevalent, but some weakly stained cells also 
visible; ++/−, strong staining present but negative cells also present; +/++/−, heterogeneous pattern with a 
mixture of strongly positive, weakly stained, and negative cells; +/++, majority of cells weakly stained, but focal 
strong staining present; +, weak staining overall; +/−, weak staining in limited areas; −/+, weak staining in 
single cells; −, no staining.
RNA-sequencing data processing and transcript quantification. Human RNA-seq data from tes-
ticular cells26 were pre-processed as previously described43,44. Briefly, paired-end reads were first mapped on the 
human genome (hg19 release) using TopHat (2.0.10)45. The RefSeq transcript annotation (GTF format)46 was 
downloaded from the UCSC genome browser (https://genome.ucsc.edu/; 6 February 2017) and the abundance 
of corresponding genes in each sample was quantified using the Cufflinks suite45 in fragments per kilobase of 
exon model per million reads mapped (FPKM). All data are available at the ReproGenomics Viewer47; (http://rgv.
genouest.org/app/#/). Gene expression data for the ECS components are provided in Supplementary Table S3.
Quantitative pcR analysis. cDNAs were synthesized from the same RNA samples as those used for 
RNA-seq26, using the iScript™ Reverse Transcription Supermix for RT-qPCR (Bio-Rad) according to manu-
facturer’s instructions. Each gene was assessed in each sample in technical duplicates on 2 ng of cDNA using 
iTaq™ Universal SYBR® Green Supermix (Bio-Rad) and a CFX384 Touch™ Real-Time PCR Detection System 
(Bio-Rad) with default program (95 °C for 3 min followed by 40 cycles of 95 °C for 10 s, 60 or 64 °C for 30 s) 
including a melting curve step (65 °C to 95 °C with a 0.5 °C increment and a hold time of 5 s before reading plate). 
Previously published primers of GAPDH and RPLP0 were used for normalisation purposes48 and results were 
analysed with the Bio-Rad CFX Manager™ software. Resulting PCR products were purified with the NucleoSpin® 
Gel 317 and PCR Clean-up kit (Macherey-Nagel) prior to sequencing using forward and reverse qPCR primers 
(Table 3 and Supplementary Figs S4 and S5).
Statistical analysis. Normal distribution of the qPCR data was first assessed for each isoform with a 
Shapiro–Wilk test as well as with a D’Agostino’s K-squared test. When normality was met (CB1 and CB1A), 
homogeneity of variances was further verified with the Brown-Forsythe test, prior to evaluating statistical differ-
ences with parametric tests, i.e. one-way ANOVA for global analysis of variances and unpaired Student’s t-test 
for pairwise comparisons. When normality was not met (CB1B and CB2A), non-parametric Kruskal–Wallis and 
Mann–Whitney U tests were used for global analysis of variances and for pairwise comparisons, respectively.
Detection of endocannabinoids in human testis tissue by MALDI imaging analysis. A 
freshly isolated human testis sample was frozen at −25 °C using water as the only adhesive. The sample was 
cut into sections 20 µm thick using a Leica CM3050S cryo-microtome (Leica Microsystems, Wetzlar, Germany). 
Subsequently, the sections were thaw-mounted on glass slides and stored at −80 °C. On the day of analysis, the 
sample slide was taken directly from the freezer to a vacuum desiccator for 10 min prior to matrix assisted laser 
desorption ionization (MALDI) imaging analysis. For the analysis, the samples were spray-coated with a 30 mg/
mL solution of 2,5-dihydroxybenzoic acid (DHB) matrix in methanol/water (50:50) containing 1% trifluoro-
acetic acid (TFA). 300 µL matrix solution was pneumatically sprayed with a flow rate of 20 µL/min from a 13 cm 
distance while the sample was rotating at 150 RPM, thereby forming a homogenous layer of fine matrix crystals 
over a circular area of approx. 30 mm diameter. The samples were analysed on a Thermo QExactive Orbitrap mass 
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spectrometer, equipped with the AP-SMALDI10 ion source (TransMIT, Giessen, Germany). The mass spectrom-
eter was operated in the positive ion mode (scan range m/z 225–900) at mass resolving power 140,000 at m/z 
200, and a mass accuracy better than 1 ppm was ensured by using a matrix background peak as lock-mass. The 
samples were imaged using a pixel size of 10 µm. Subsequent microscope analysis showed laser ablation craters 
of approx. 7 µm diameter, confirming that oversampling was not performed. The raw data were converted to 
imzML using an imzML converter49 (available from www.maldi-msi.org), and MSiReader 0.09 was used to gen-
erate images50. The images were created using a bin width of 5 ppm.
Data Availability
The data obtained in the course of this study are available as tables and figures in Supplementary Information. All 
initial raw RNA-sequencing data are available at the ReproGenomics Viewer47 (http://rgv.genouest.org/app/#/). 
Additional immunohistochemical images are available upon a direct contact with the corresponding author.
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